208 related articles for article (PubMed ID: 19285649)
1. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks.
Poon LC; Chelemen T; Minekawa R; Frisova V; Nicolaides KH
Am J Obstet Gynecol; 2009 May; 200(5):508.e1-6. PubMed ID: 19285649
[TBL] [Abstract][Full Text] [Related]
2. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy.
Spencer K; Cowans NJ
J Matern Fetal Neonatal Med; 2007 Sep; 20(9):645-50. PubMed ID: 17701664
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum placental growth factor at 11-13 weeks in chromosomally abnormal pregnancies.
Zaragoza E; Akolekar R; Poon LC; Pepes S; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Apr; 33(4):382-6. PubMed ID: 19277983
[TBL] [Abstract][Full Text] [Related]
4. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester.
Valinen Y; Peuhkurinen S; Järvelä IY; Laitinen P; Ryynanen M
Gynecol Obstet Invest; 2010; 70(1):60-3. PubMed ID: 20197665
[TBL] [Abstract][Full Text] [Related]
5. First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker.
Tørring N; Ball S; Wright D; Sarkissian G; Guitton M; Darbouret B
Reprod Biol Endocrinol; 2010 Oct; 8():129. PubMed ID: 21034452
[TBL] [Abstract][Full Text] [Related]
6. First trimester maternal serum PAPP-A, beta-hCG and ADAM12 in prediction of small-for-gestational-age fetuses.
Pihl K; Larsen T; Krebs L; Christiansen M
Prenat Diagn; 2008 Dec; 28(12):1131-5. PubMed ID: 19003798
[TBL] [Abstract][Full Text] [Related]
7. Modeling Down syndrome screening performance using first-trimester serum markers.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):134-9. PubMed ID: 21800388
[TBL] [Abstract][Full Text] [Related]
8. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome.
Laigaard J; Spencer K; Christiansen M; Cowans NJ; Larsen SO; Pedersen BN; Wewer UM
Prenat Diagn; 2006 Oct; 26(10):973-9. PubMed ID: 16892462
[TBL] [Abstract][Full Text] [Related]
9. Maternal serum placental protein 13 at eleven to thirteen weeks in chromosomally abnormal pregnancies.
Akolekar R; Pérez Penco JM; Skyfta E; Rodríguez Calvo J; Nicolaides KH
Fetal Diagn Ther; 2010; 27(2):72-7. PubMed ID: 20332643
[TBL] [Abstract][Full Text] [Related]
10. ADAM12s as a first-trimester screening marker of trisomy.
Wortelboer EJ; Linskens IH; Koster MP; Stoutenbeek P; Cuckle H; Blankenstein MA; Visser GH; van Vugt JM; Schielen PC
Prenat Diagn; 2009 Sep; 29(9):866-9. PubMed ID: 19544290
[TBL] [Abstract][Full Text] [Related]
11. [Second trimester screening for trisomy 21 using ADAM12-S as a maternal serum marker].
Jiang T; Lv L; Yang B; Sun YJ; Zhang XJ; Sun Y; Xu QJ; Xu ZF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):314-8. PubMed ID: 22678798
[TBL] [Abstract][Full Text] [Related]
12. Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies.
Koster MP; Wortelboer EJ; Stoutenbeek P; Visser GH; Schielen PC
Prenat Diagn; 2010 May; 30(5):413-7. PubMed ID: 20306463
[TBL] [Abstract][Full Text] [Related]
13. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
14. Maternal serum ADAM12 in Chinese women undergoing screening for aneuploidy in the first trimester.
Liao C; Han J; Sahota D; Li DZ; Sun Q; Lin L; Zhou JY; Yang X; Pan M; Huang YN
J Matern Fetal Neonatal Med; 2010 Nov; 23(11):1305-9. PubMed ID: 20230315
[TBL] [Abstract][Full Text] [Related]
15. Impact of bias in serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A multiples of the median levels on first-trimester screening for trisomy 21.
Wright D; Abele H; Baker A; Kagan KO
Ultrasound Obstet Gynecol; 2011 Sep; 38(3):309-13. PubMed ID: 21400623
[TBL] [Abstract][Full Text] [Related]
16. Maternal serum ADAM12s as a marker of rare aneuploidies in the first or second trimester of pregnancy.
Spencer K; Cowans NJ; Stamatopoulou A
Prenat Diagn; 2007 Dec; 27(13):1233-7. PubMed ID: 17987603
[TBL] [Abstract][Full Text] [Related]
17. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
[TBL] [Abstract][Full Text] [Related]
18. Maternal serum biochemistry at 11-13(+6) weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening.
Cicero S; Spencer K; Avgidou K; Faiola S; Nicolaides KH
Prenat Diagn; 2005 Nov; 25(11):977-83. PubMed ID: 16245371
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum ADAM12s as a potential marker of trisomy 21 prior to 10 weeks of gestation.
Spencer K; Vereecken A; Cowans NJ
Prenat Diagn; 2008 Mar; 28(3):209-11. PubMed ID: 18264948
[TBL] [Abstract][Full Text] [Related]
20. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
